[31]
Fan, Z.; Yi, Y.; Ping, S.; Zhenku, G. Microwave-assisted extraction of rutin and quercetin from the stalks of <em>Euonymus alatus</em> (Thunb.). Sieb., 2009, 20(1), 33-37.
[91]
Sun, H.; Niisato, N.; Marunaka, Y. Quercetin diminishes the cAMP-stimulated Cl- secretion by blocking Na+,K+ -ATPase in epithelial cells. J. Physiol. Sci., 2014, 64, S116.
[130]
Lines, T.C. Method for treating zika virus infection with quercetin-containing compositions. US20190192481, 2019.
[131]
Chodoeva, A. Quercetin-based composition for treating rhinosinusitis. CA3083179A1, 2019.
[132]
HU K.. Quercetin nanoparticles WO201872942A1, 2018.
[133]
Fesenko, S.; Shneider, A.; Gabai, V. Methods of monitoring safety of quercetin compositions. US11156623B2, 2021.
[134]
Fesenko, S.; Shneider, A.; Gabai, V. compositions and containers for reducing solid form quercetin degradation and 2-(3,4-dihydroxybenzoyloxy)-4,6-dihydroxybenzoic acid toxic byproducts thereof US20200197355A1, 2020.
[135]
Das, S.K. Tag H. A process for isolation and yield increase of flavonoid compound/quercetin from plant houttuynia cordata thunb by uv-b exposure. AU2021103279A4, 2021.
[136]
Ronchi, M. Powder solid dispersions comprising quercetin, process for their preparation and formulations thereof. US20200206186A1, 2022.
[137]
SAAD W.A.. Park D.H. Zinc- and quercetin-based pharmaceutical formulation for the production of antiviral medication effective for dengue and zika. WO2018039755A1, 2018.
[138]
HONG Y.D.. Quercetin-based compound. US10550142B2, 2020.
[139]
Danoux, L.; Henry, F.; Pain, S. New cosmetic use of a combination of oenothein-B and quercetin-3-O-glucuronide. FR3099701A1, 2022.
[140]
MAKITRUK V.. Water-soluble solid dispersion of quercetin, forms thereof, a method of obtaining thereof, use of alkaline agent, and a kit. WO2021167580A1, 2021.
[141]
Farber, B.; Farber, S.; Martynov, A.V. Cosmetological and pharmaceutical composition based on combinatorial quercetin derivative. US11229622B2, 2022.
[142]
Li, W.; Guo, Y.; Zhang, Z.; Zhang, Z.; Wen, L.; Gao, X. Use of quercetin in plant aging promoter. US11251961B2, 2022.
[143]
Du, R.; Gao, Y.; Li, Y.; Tan, J.; Wu, R.; Wu, S.; Yang, L.; Zhang, Y.; Zhao, Y. Quercetin compound nanoemulsion based on mongolian medicine sendeng-4 and preparation method therefor. AU2020101834A4, 2020.
[144]
Fesenko, S.; Shneider, A.; Gabai, V. Methods, compositions and containers for reducing solid form quercetin degradation and 2,4,6-trihydroxybenzoic acid toxic byproduct thereof. US20200197354A1, 2020.
[145]
KALAMOUNI C.E.. Despres P. Use of quercetin-3-o-glucoside for the treatment of flavivirus infections. WO2019185579A1, 2019.
[146]
Alexandre, A.L.; Fabrini, L.A.A.; Glauciemar, D.V.V.; Guilherme, D.T.; Gustavo, S.G.D.C.; Leonarde, D.N.R.; Maria, S.A.; Orlando, V.D.S.; Renata, D.; Virgílio, D.C.D.A. solid dispersions of quercetin and hydroxypropyl methylcellulose developed for therapeutic products. BR102017004399A2, 2018.
[147]
Rocha, C.D.; Vale, D.L.D.; Baracat, M.M.; Sfeir, N.; Martinez, R.M.; Casagrande, R.; Georgetti, S.R.; Junior, W.A.V. Georgetti S.R., Junior W.A.V. microencapsulated quercetin with biopolymers, in topical formulation, for the treatment of photoaging and photo carcogenesis BR102019016665A2, 2021.
[148]
Hongjin, B.; Zhongbo, Z.; Ruirui, L.; Jinlong, Z.; Aizhi, H.; Yuyao, Y. Method for extracting, separating and purifying blood fat reducing active compound quercetin-3-O-beta-D-glucoside from Jun jujubes in southern Xinjiang. CN105968152A, 2016.
[149]
Gabrielle, A.R.D.S.; Simone, S.D.S.O.; Sorele, B.F. process for producing quercetin BR102018074553, 2020.
[150]
SMITH M.. Quercetin enhancement formulation. WO2021189109A1, 2021.
[151]
Oumar-Mahamat, H.; Webster, M.N.; Ng, M.K.; Cheng, H.; Buzdygon, K.J.; Deighton, S. Lubricating oil compositions having functionalized quercetin antioxidants. US20200190425A1, 2020.
[152]
Schack, D.M.; Campbell, A.W. Anthocyanin and quercetin based formulations for improved respiratory health. US20210393579A1, 2021.
[153]
Jie, Z. Injection pharmaceutical composition capable of improving stability of quercetin medication injection preparation. CN105902487, 2016.
[154]
Seung-heon, H.; Ye, J.; Chang-ryul, L. Chang-ryul L. A pharmaceutical comprising quercetin for treating of preventing colorectal cancer. KR20170089989A, 2017.
[155]
Kang, H.J.; Jo, H.S.; Heo, S. Pharmaceutical composition for the treatment of Epstein-Barr virus-positive gastric cancer, comprising an extract of Ganoderma lucidum and quercetin as an active ingredient. KR102187951B1, 2020.
[156]
Nianzeng, X.; Dong, C.; Feiya, Y. Application of quercetin in preparation of prostate cancer radiotherapy sensitizing drugs. CN112656785A, 2021.
[157]
Meigui, H.; Yu, W.; Jin, W.; Qianqian, C.; Ruifeng, Y.; Yaosong, W. High internal phase emulsion with quercetin stabilized by soy protein isolate-pectin compound and preparation method thereof. CN110498935B, 2021.
[158]
Tao, L.; Haiyun, T. Quercetin nanoparticles and preparation method thereof CN111686078A, 2020.
[159]
Junliang, Z. Method for extracting quercetin from sophora flower bud by using cyclodextrin. CN105399716A, 2016.
[160]
Baotang, Z.; Bin, F.; Jian, Z.; Jiazhong, T.; Na, L.; Guifang, L. Method for recovering quercetin from stevioside extraction residues and application of quercetin. CN114014828A, 2022.
[161]
Dapeng, L.; Hui, L. Application of miR-16-5p as target in regulating quercetin and EGCG to synergistically protect islet cell injury. CN111494632B, 2021.
[162]
Qiangqiang, M. Method for extracting and purifying quercetin from young apple fruits. CN112409312A, 2021.
[163]
Hongli, Z. A kind of compound recipe Quercetin nanoemulsion antisenescence health product. CN106137959A, 2016.
[164]
Zhongxi, S.; Meichi, W.; Xiaohui, S. Sterilizing equipment is used in production of quercetin extract product. CN213526499U, 2021.
[165]
Mori, T.; Mori, T.; Kamikita, K.; Kamikita, K.; Kamikita, K. Agent for increasing content of quercetin in onion and onion cultivation method. JP2019170321A, 2022.
[166]
Danshi, Z.; Hongyun, Z.; Jun, L.; He, L.; Hongsheng, L.; Lina, Y.; Chunguang, H.; Hongwei, Z.; Xiaojuan, L. The fluffy middle Quercetin of alkali is isolated and purified using supercritical analogue moving bed chromatographic system. CN107935977A, 2018.
[167]
Sang-soo, L.; Ashshi, R.S.; Sharma, G.; Lee, Y. Method for preparing quercetin-selenium nanoparticles and quercetin-selenium nanoparticles prepared by the method. KR102357112B1, 2022.
[168]
Nianzeng, X.; Feiya, Y.; Dong, C.; Lingquan, M. Quercetin and curcumin drug combination are preparing the application in treating prostate cancer product. CN107595834A, 2018.
[169]
Hong, Y.D.; Hong, Y.D.; Choi, M.S.; Choi, M.S.; Cho, S.Y.; Cho, S.Y.; Kim, J.G.; Kim, J.G. Composition for improving cognitive function comprising a novel quercetin compound. JP2019535652A, 2019.
[170]
Liang, Z.; Wei, L.; Liang, C. Preparation method and application of quercetin and MicroRNA-150 co-loaded cationic solid lipid nanoparticles. CN112089846A, 2020.
[171]
Jun, L.; Wenfei, L. Method for extracting quercetin from pomegranate peel. CN113717139A, 2021.
[172]
Shenquan, L.; Mingfei, S.; Nanshan, Q.; Minna, L.; Caiyan, W.; Juan, L.; Xuhui, L.; Junjing, H.; Haiming, C.; Wenwan, X.; Zeng, L.; Jianyu, Z.; Mingquan, X. Application of quercetin and derivatives thereof. CN111494362A, 2020.
[173]
Dong-wook, K.; Jong-yoon, J. Quercetin derivative, pharmaceutical composition for preventing or treating cancer comprising the same, and method for synthesizing the same. KR102283835B1, 2021.
[174]
Brown, D. Treatment of fragile x syndrome with ibudilast in combination with metformin, cannbidiol, sertraline or quercetin. WO2021044158A1, 2021.